Hunter C. Smith - 09 Feb 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Financial Officer
Signature
/s/ Hunter C. Smith
Issuer symbol
RYTM
Transactions as of
09 Feb 2024
Net transactions value
-$97,441
Form type
4
Filing time
13 Feb 2024, 20:50:20 UTC
Previous filing
05 Feb 2024
Next filing
21 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +4,063 +5.4% 79,278 09 Feb 2024 Direct F1
transaction RYTM Common Stock Options Exercise +2,344 +3% 81,622 11 Feb 2024 Direct F1
transaction RYTM Common Stock Sale $62,118 -1,209 -1.5% $51.38 80,413 12 Feb 2024 Direct F2
transaction RYTM Common Stock Sale $35,322 -709 -0.88% $49.82 79,704 13 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -4,063 -33% $0.000000 8,124 09 Feb 2024 Common Stock 4,063 Direct F1, F3
transaction RYTM Restricted Stock Units Options Exercise $0 -2,344 -50% $0.000000 2,343 11 Feb 2024 Common Stock 2,344 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
F3 The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.
F4 The restricted stock units vest or have vested as to 25% of the total shares on each of February 11 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.